Overview of Chronic Rhinosinusitis with Nasal Polyps
References
- Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020 Feb 20;58(Suppl S29):1–464. doi: 10.4193/Rhin20.600. PMID: 32077450.
- Grayson JW, Hopkins C, Mori E, Senior B, Harvey RJ. Contemporary Classification of Chronic Rhinosinusitis Beyond Polyps vs No Polyps: A Review. JAMA Otolaryngol Head Neck Surg. 2020 Sep 1;146(9):831–838. doi: 10.1001/jamaoto.2020.1453. Erratum in: JAMA Otolaryngol Head Neck Surg. 2020 Sep 1;146(9):876. doi: 10.1001/jamaoto.2020.2776. PMID: 32644117.
- Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, et al. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology. 2023 Jun 1;61(3):194–202. doi: 10.4193/Rhin22.489. PMID: 36999780.
- Keating MK, Phillips JC, Phillips J. Chronic Rhinosinusitis. Am Fam Physician. 2023 Oct;108(4):370–377. PMID: 37843944.
- Zeroli C, Gorica A, Monti G, Castelnuovo PGM, Bignami M, Macchi A. A systematic review of randomised controlled trials on topical nasal steroids. Acta Otorhinolaryngol Ital. 2024 Apr;44(2):71–75. doi: 10.14639/0392-100X-N2745. PMID: 38651550; PMCID: PMC11042551.
- Shin JJ, Wilson M, McKenna M, Rosenfeld R, Ammon K, Crosby D, et al. Clinical Practice Guideline: Surgical Management of Chronic Rhinosinusitis. Otolaryngol Head Neck Surg. 2025 Jun;172 Suppl 2:S1–S47. doi: 10.1002/ohn.1287. PMID: 40424072.
- Hildenbrand T, Milger-Kneidinger K, Baumann I, Weber R. The Diagnosis and Treatment of Chronic Rhinosinusitis. Dtsch Arztebl Int. 2024 Sep 20;121(19):643–653. doi: 10.3238/arztebl.m2024.0167. PMID: 39173076; PMCID: PMC11741551.
- Hellings PW, Alobid I, Anselmo-Lima WT, Bernal-Sprekelsen M, Bjermer L, Caulley L, et al. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care. Allergy. 2024 May;79(5):1123–1133. doi: 10.1111/all.15982. Epub 2023 Dec 18. PMID: 38108602.
- Millarelli S, Loperfido A, Mammarella F, Giorgione C, Celebrini A, Del Ninno M, et al. A Practical Clinical Protocol for Monitoring Patients with Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyposis Treated with Biologics. Allergy Rhinol (Providence). 2022 Jan 31;13:21526567221074335. doi: 10.1177/21526567221074335. PMID: 35127200; PMCID: PMC8808004.
- Chiu J, Fastenberg J, Tong C, Navetta-Modrov B, Marcus S. Biologics for Chronic Rhinosinusitis With Nasal Polyposis: Current Landscape and Future Directions. Laryngoscope Investig Otolaryngol. 2025 Oct 18;10(5):e70282. doi: 10.1002/lio2.70282. PMID: 41112679; PMCID: PMC12535206.
- Papacharalampous GX, Constantinidis J, Fotiadis G, Zhang N, Bachert C, Katotomichelakis M. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy. Int Forum Allergy Rhinol. 2024 Jan;14(1):96–109. doi: 10.1002/alr.23234. Epub 2023 Jul 18. PMID: 37394893.
- Gevaert P, Desrosiers M, Cornet M, Mullol J, De Corso E, Keles Turel N, et al. Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials. Lancet. 2025 Mar 15;405(10482):911–926. doi: 10.1016/S0140-6736(25)00197-7. Epub 2025 Mar 1. Erratum in: Lancet. 2025 Dec 6;406(10520):2630. doi: 10.1016/S0140-6736(25)02429-8. Erratum in: Lancet. 2026 May 23;407(10543):2014. doi: 10.1016/S0140-6736(26)00990-6. PMID: 40037388.
- Sedaghat AR, Kuan EC, Scadding GK. Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors. J Allergy Clin Immunol Pract. 2022 Jun;10(6):1395–1403. doi: 10.1016/j.jaip.2022.01.016. Epub 2022 Jan 29. PMID: 35092822.
- Khan A, Vandeplas G, Huynh TMT, Joish VN, Mannent L, Tomassen P, et al. The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2019 Feb 1;57(1):32–42. doi: 10.4193/Rhin17.255. PMID: 29911211.
- Starry A, Hardtstock F, Wilke T, Weihing J, Ultsch B, Wernitz M, et al. Epidemiology and treatment of patients with Chronic rhinosinusitis with nasal polyps in Germany-A claims data study. Allergy. 2022 Sep;77(9):2725–2736. doi: 10.1111/all.15301. Epub 2022 Apr 8. PMID: 35357726; PMCID: PMC9542419.
- Pfaar O, Peters AT, Taillé C, Teeling T, Silver J, Chan R, et al. Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach. Clin Transl Allergy. 2025 Jan;15(1):e70010. doi: 10.1002/clt2.70010. PMID: 39794887; PMCID: PMC11723824.
- Mullol J, Sastre J, Dominguez-Ortega J, Blanco-Aparicio M, Castillo Vizuete JA, Alobid I, et al. Prevalence of chronic rhinosinusitis without/with nasal polyps according to severity in Spain. Rhinology. 2024 Aug 1;62(4):421–431. doi: 10.4193/Rhin23.341. PMID: 38830185.
- Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract. 2016 Jul–Aug;4(4):565–72. doi: 10.1016/j.jaip.2016.04.012. PMID: 27393770; PMCID: PMC4939220.
- Stevens WW, Peters AT, Suh L, Norton JE, Kern RC, Conley DB, et al. A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men. Immun Inflamm Dis. 2015 Mar;3(1):14–22. doi: 10.1002/iid3.46. Epub 2015 Feb 12. PMID: 25866636; PMCID: PMC4386911.
- Chen S, Zhou A, Emmanuel B, Thomas K, Guiang H. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Curr Med Res Opin. 2020 Nov;36(11):1897–1911. doi: 10.1080/03007995.2020.1815682. Epub 2020 Sep 25. PMID: 32847417.
- Bhattacharyya N, Villeneuve S, Joish VN, Amand C, Mannent L, Amin N, et al. Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope. 2019 Sep;129(9):1969–1975. doi: 10.1002/lary.27852. Epub 2019 Feb 5. PMID: 30720213; PMCID: PMC6767455.
- Hulse KE, Stevens WW, Tan BK, Schleimer RP. Pathogenesis of nasal polyposis. Clin Exp Allergy. 2015 Feb;45(2):328–46. doi: 10.1111/cea.12472. PMID: 25482020; PMCID: PMC4422388.
- Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps. J Asthma Allergy. 2021 Feb 11;14:127–134. doi: 10.2147/JAA.S290424. PMID: 33603409; PMCID: PMC7886239.
- Marglani O, Al Abri R, Al Ahmad M, Alsaleh S, Abuzakouk M, Kamel R. Management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the Pan-Arab Region: Consensus Recommendations from a Multidisciplinary Expert Working Group. J Asthma Allergy. 2023 Sep 29;16:1055–1063. doi: 10.2147/JAA.S413610. PMID: 37795191; PMCID: PMC10547061.
- Hopkins C. Chronic Rhinosinusitis with Nasal Polyps. N Engl J Med. 2019 Jul 4;381(1):55–63. doi: 10.1056/NEJMcp1800215. PMID: 31269366.
- Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy. 2011 Sep;66(9):1216–23. doi: 10.1111/j.1398-9995.2011.02646.x. Epub 2011 May 24. PMID: 21605125.
- Boztepe F, Ural A, Paludetti G et al. Pathophysiology of Chronic Rhinosinusitis with Nasal Polyps. In: Cingi C, Bayar Muluk N (eds), All Around the Nose: Basic Science, Diseases and Surgical Management. Cham: Springer International Publishing, 2020, 373–9.
https://doi.org/10.1007/978-3-030-21217-9_43 . - Rank MA, Chu DK, Bognanni A, Oykhman P, Bernstein JA, Ellis AK, et al. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2023 Feb;151(2):386–398. doi: 10.1016/j.jaci.2022.10.026. Epub 2022 Nov 9. PMID: 36370881.
- Kim do H, Han K, Kim SW. Effect of Chronic Rhinosinusitis With or Without Nasal Polyp on Quality of Life in South Korea: 5th Korea National Health and Nutrition Examination Survey Korean. Clin Exp Otorhinolaryngol. 2016 Jun;9(2):150–6. doi: 10.21053/ceo.2015.01053. Epub 2016 Apr 19. PMID: 27090274; PMCID: PMC4881329..
- Chung JH, Lee YJ, Kang TW, Kim KR, Jang DP, Kim IY, et al. Altered Quality of Life and Psychological Health (SCL-90-R) in Patients With Chronic Rhinosinusitis With Nasal Polyps. Ann Otol Rhinol Laryngol. 2015 Aug;124(8):663–70. doi: 10.1177/0003489415576181. Epub 2015 Mar 5. PMID: 25743178.
- Higgins TS, Douglas JE, Kern RC, Palmer JN, Reitsma S, Wagenmann M, et al. Importance of Smell Loss to Patients With Chronic Rhinosinusitis With Nasal Polyps: Options for Management and Recovery. Clin Transl Allergy. 2026 Feb;16(2):e70149. doi: 10.1002/clt2.70149. PMID: 41619184; PMCID: PMC12860424.
- Malvezzi L, Seccia V, Moffa A, Canevari FRM, Baiardini I, Barbaglia S, et al. The Impact and Burden of Chronic Rhinosinusitis with Nasal Polyps on Patients and Their Family Caregivers: A Nationally Representative Survey. Healthcare (Basel). 2025 Feb 17;13(4):430. doi: 10.3390/healthcare13040430. PMID: 39997305; PMCID: PMC11855350.
- Håkansson KEJ, Andersen SAW, Løkke A, Hilberg O, Ibsen R, Ulrik CS, et al. Individual and Societal Economic Burden of Chronic Rhinosinusitis with or Without Nasal Polyps. Med Sci (Basel). 2026 Feb 2;14(1):67. doi: 10.3390/medsci14010067. PMID: 41718115; PMCID: PMC12921935.
- Lourijsen ES, Fokkens WJ, Reitsma S. Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps. Rhinology. 2020 Jun 1;58(3):213–217. doi: 10.4193/Rhin19.468. PMID: 32415826.
- Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic Rhinosinusitis with Nasal Polyps and Asthma. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1133–1141. doi: 10.1016/j.jaip.2020.09.063. Epub 2020 Oct 13. PMID: 33065369.
- Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. Allergy. 2019 Jan;74(1):28–39. doi: 10.1111/all.13599. Epub 2018 Oct 2. PMID: 30216468.
- Murtomäki A, Helevä A, Torkki P, Haukka J, Julkunen-Iivari A, Lemmetyinen R, et al. Comorbidities of chronic rhinosinusitis in children and adults. Clin Transl Allergy. 2024 Apr;14(4):e12354. doi: 10.1002/clt2.12354. PMID: 38658181; PMCID: PMC11043011.
- Fan H, Han Z, Gong X, Wu Y, Fu Y, Zhu T, et al. Prevalence and predictors of depression and anxiety in patients with chronic rhinosinusitis: a systematic review and meta-analysis. BMJ Open. 2024 Mar 15;14(3):e079273. doi: 10.1136/bmjopen-2023-079273. PMID: 38490652; PMCID: PMC10946353.
- Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy. 2012 Jan;67(1):91–8. doi: 10.1111/j.1398-9995.2011.02709.x. Epub 2011 Nov 4. PMID: 22050239.
- Castagnoli R, Licari A, Brambilla I, Tosca M, Ciprandi G, Marseglia GL. An update on the role of chronic rhinosinusitis with nasal polyps as a comorbidity in severe asthma. Expert Rev Respir Med. 2020 Dec;14(12):1197–1205. doi: 10.1080/17476348.2020.1812388. Epub 2020 Sep 2. PMID: 32875924.
- Ragab A, Clement P, Vincken W. Objective assessment of lower airway involvement in chronic rhinosinusitis. Am J Rhinol. 2004 Jan–Feb;18(1):15–21. PMID: 15035566.
- Bachert C, Zhang N, Holtappels G, De Lobel L, van Cauwenberge P, Liu S, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol. 2010 Nov;126(5):962–8, 968.e1–6. doi: 10.1016/j.jaci.2010.07.007. PMID: 20810157.
- Langdon C, Mullol J. Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy. 2016 Mar 14;9:45–53. doi: 10.2147/JAA.S86251. PMID: 27042129; PMCID: PMC4798207.
- Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 Mar;11(3):213–739. doi: 10.1002/alr.22741. Erratum in: Int Forum Allergy Rhinol. 2022 Jul;12(7):974. doi: 10.1002/alr.22987. PMID: 33236525.
- Benninger MS, Holy CE. The impact of endoscopic sinus surgery on health care use in patients with respiratory comorbidities. Otolaryngol Head Neck Surg. 2014 Sep;151(3):508–15. doi: 10.1177/0194599814536369. Epub 2014 Jun 3. PMID: 24894312.
- Håkansson K, Thomsen SF, Konge L, Mortensen J, Backer V, von Buchwald C. A comparative and descriptive study of asthma in chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2014 Sep–Oct;28(5):383–7. doi: 10.2500/ajra.2014.28.4076. PMID: 25198023.
- Stevens WW, Peters AT, Hirsch AG, Nordberg CM, Schwartz BS, Mercer DG, et al. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract. 2017 Jul–Aug;5(4):1061–1070.e3. doi: 10.1016/j.jaip.2016.12.027. Epub 2017 Mar 9. PMID: 28286156; PMCID: PMC5503772.
- Fahy JV. Type 2 inflammation in asthma--present in most, absent in many. Nat Rev Immunol. 2015 Jan;15(1):57–65. doi: 10.1038/nri3786. PMID: 25534623; PMCID: PMC4390063.
- Nappi E, Marzio V, Giombi F, Costanzo G, Merli S, Nicolosi S, et al. Chronic rhinosinusitis with and without nasal polyps: the state-of-the-art of current treatment strategies and future developments. Front Allergy. 2025 Dec 15;6:1714577. doi: 10.3389/falgy.2025.1714577. PMID: 41473842; PMCID: PMC12746665.
- Tănase MI, Tanase M, Cosgarea M, Radeanu GD, Pop SS, Maniu AA. Biologic Treatments for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): A Comparative Review of Efficiency and Risks. Cureus. 2025 Jan 22;17(1):e77804. doi: 10.7759/cureus.77804. PMID: 39844880; PMCID: PMC11751697.
- Bachert C, Zhang N, Cavaliere C, Weiping W, Gevaert E, Krysko O. Biologics for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2020 Mar;145(3):725–739. doi: 10.1016/j.jaci.2020.01.020. PMID: 32145872.
- Potter PC, Pawankar R. Indications, efficacy, and safety of intranasal corticosteriods in rhinosinusitis. World Allergy Organ J. 2012 Jan;5(Suppl 1):S14–7. doi: 10.1097/WOX.0b013e31823f7216. Epub 2012 Jan 13. PMID: 23268478; PMCID: PMC3488931.
- Kanjanawasee D, Seresirikachorn K, Chitsuthipakorn W, Snidvongs K. Hypertonic Saline Versus Isotonic Saline Nasal Irrigation: Systematic Review and Meta-analysis. Am J Rhinol Allergy. 2018 Jul;32(4):269–279. doi: 10.1177/1945892418773566. Epub 2018 May 18. PMID: 29774747.
- Chong LY, Head K, Hopkins C, Philpott C, Schilder AG, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011996. doi: 10.1002/14651858.CD011996.pub2. PMID: 27115217; PMCID: PMC9393647.
- Bognanni A, Chu DK, Rank MA, Bernstein J, Ellis AK, Golden D, et al. Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis. J Allergy Clin Immunol. 2022 Dec;150(6):1447–1459. doi: 10.1016/j.jaci.2022.07.023. Epub 2022 Aug 12. PMID: 35970310.
- Rollema C, van Roon EN, Ekhart C, van Hunsel FPAM, de Vries TW. Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center. Drugs Real World Outcomes. 2022 Sep;9(3):321–331. doi: 10.1007/s40801-022-00301-x. Epub 2022 Jun 3. PMID: 35661117; PMCID: PMC9392821.
- Campbell RG. Risks and management of long-term corticosteroid use in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2018 Feb;26(1):1–7. doi: 10.1097/MOO.0000000000000421. PMID: 29059082.
- Poetker DM, Jakubowski LA, Lal D, Hwang PH, Wright ED, Smith TL. Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2013 Feb;3(2):104–20. doi: 10.1002/alr.21072. Epub 2012 Aug 7. PMID: 22887970.
- Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011991. doi: 10.1002/14651858.CD011991.pub2. PMID: 27113367; PMCID: PMC8504433.
- Poetker DM. Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps: Risks and benefits. Am J Rhinol Allergy. 2015 Sep–Oct;29(5):339–42. doi: 10.2500/ajra.2015.29.4223. PMID: 26358344..
- Chan Y, Corriveau MN, Beach J, Reynolds J, Usuba K, Thayaparan D, et al. Oral corticosteroid overexposure: characterizing oral corticosteroid use in patients with chronic rhinosinusitis with nasal polypS in Canada (ACTIONS) results. Allergy Asthma Clin Immunol. 2025 Dec 4;21(1):51. doi: 10.1186/s13223-025-00989-w. PMID: 41345729; PMCID: PMC12687512.
- Huang Z, Zhou B. Clarithromycin for the treatment of adult chronic rhinosinusitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2019 May;9(5):545–555. doi: 10.1002/alr.22281. Epub 2019 Jan 10. PMID: 30629811.
- Lourijsen ES, Reitsma S, Vleming M, Hannink G, Adriaensen GFJPM, Cornet ME, et al. Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial. Lancet Respir Med. 2022 Apr;10(4):337–346. doi: 10.1016/S2213-2600(21)00457-4. Epub 2022 Jan 7. PMID: 35012708.
- DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2017 Mar;127(3):550–555. doi: 10.1002/lary.26391. Epub 2016 Nov 12. PMID: 27859303; PMCID: PMC5321782.
- Hopkins C, Rimmer J, Lund VJ. Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis. Rhinology. 2015 Mar;53(1):10–7. doi: 10.4193/Rhino13.217. PMID: 25756072.
- Fandiño M, Macdonald KI, Lee J, Witterick IJ. The use of postoperative topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis. Am J Rhinol Allergy. 2013 Sep–Oct;27(5):e146–57. doi: 10.2500/ajra.2013.27.3950. PMID: 24119596; PMCID: PMC3899544.
- Jaksha AF, Weitzel EK, Laury AM. Recent advances in the surgical management of rhinosinusitis. F1000Res. 2016 Sep 26;5:F1000 Faculty Rev-2377. doi: 10.12688/f1000research.9163.1. PMID: 27746900; PMCID: PMC5040157.
- Wallace DV. Treatment options for chronic rhinosinusitis with nasal polyps. Allergy Asthma Proc. 2021 Nov 1;42(6):450–460. doi: 10.2500/aap.2021.42.210080. PMID: 34871152.
- Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Solà I, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines. Allergy. 2021 Aug;76(8):2337–2353. doi: 10.1111/all.14809. Epub 2021 Mar 24. PMID: 33683704.
- Armstrong MF, Senior BA. Biologics in Chronic Rhinosinusitis with Nasal Polyps: The Otolaryngologist’s Perspective. Curr Allergy Asthma Rep. 2026 Jan 10;26(1):4. doi: 10.1007/s11882-025-01243-4. PMID: 41518424.
- Xu X, Lin J, Luo M, Wu Q. Which Is the Best Biologic for Nasal Polyps: An Updated Network Meta-Analysis. Clin Transl Allergy. 2025 Nov;15(11):e70114. doi: 10.1002/clt2.70114. PMID: 41178615; PMCID: PMC12580786.
- Lipworth BJ, Han JK, Desrosiers M, Hopkins C, Lee SE, Mullol J, et al. Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps. N Engl J Med. 2025 Mar 27;392(12):1178–1188. doi: 10.1056/NEJMoa2414482. Epub 2025 Mar 1. PMID: 40106374.
- Wu Q, Zhang Y, Kong W, Wang X, Yuan L, Zheng R, et al. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis. Int Arch Allergy Immunol. 2022;183(3):279–288. doi: 10.1159/000519228. Epub 2021 Oct 4. PMID: 34607329.
- Rampi A, Vinciguerra A, Tanzini U, Bussi M, Trimarchi M. Comparison of guidelines for prescription and follow-up of biologics for chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol. 2023 Jan;280(1):39–46. doi: 10.1007/s00405-022-07634-x. Epub 2022 Sep 13. PMID: 36098864.
- Cai S, Xu S, Zhao Y, Zhang L. Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Real-World Evidence. Allergy. 2025 May;80(5):1256–1270. doi: 10.1111/all.16499. Epub 2025 Feb 22. PMID: 39985317; PMCID: PMC12105074.
- Hopkins C, McKenzie JL, Anari S, Carrie S, Ramakrishnan Y, Kara N, et al. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps. Clin Otolaryngol. 2021 Sep;46(5):1037–1043. doi: 10.1111/coa.13779. Epub 2021 Apr 22. PMID: 33817954.
- Book R, Eligal S, Tal Y, Eliashar R. Biological Treatment for Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: Preliminary Real-World Results from a Tertiary Medical Center. J Clin Med. 2023 May 25;12(11):3671. doi: 10.3390/jcm12113671. PMID: 37297865; PMCID: PMC10253462.
- Stryjewska-Makuch G, Humeniuk-Arasiewicz M, Niemiec-Urbańczyk M, Michalak-Kolarz M, Glȕck J. Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyps: Case Analysis and Proposal of a Qualification Scheme. Otolaryngol Pol. 2025 Nov 25;79(6):1–8. doi: 10.5604/01.3001.0055.4321. PMID: 41368995.
- Khan AH, Reaney M, Guillemin I, Nelson L, Qin S, Kamat S, et al. Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal Polyps. Laryngoscope. 2022 May;132(5):933–941. doi: 10.1002/lary.29766. Epub 2021 Aug 26. PMID: 34437720; PMCID: PMC9292332.
- Jacobs JS, Han JK, Lee JK, Laidlaw TM, Martin NL, Caveney S, et al. Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps. Adv Ther. 2025 Jan;42(1):510–522. doi: 10.1007/s12325-024-03006-5. Epub 2024 Nov 8. PMID: 39514041; PMCID: PMC11782459.
- Ramkumar SP, Lal D, Miglani A. Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps. Front Allergy. 2023 Mar 10;4:1137907. doi: 10.3389/falgy.2023.1137907. PMID: 36970067; PMCID: PMC10036764.
- De Corso E, Bilò MB, Matucci A, Seccia V, Braido F, Gelardi M, et al. Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement. J Pers Med. 2022 May 23;12(5):846. doi: 10.3390/jpm12050846. PMID: 35629268; PMCID: PMC9143504.
- Park DY, Choi JH, Kim DK, Jung YG, Mun SJ, Min HJ, et al. Clinical Practice Guideline: Nasal Irrigation for Chronic Rhinosinusitis in Adults. Clin Exp Otorhinolaryngol. 2022 Feb;15(1):5–23. doi: 10.21053/ceo.2021.00654. Epub 2022 Feb 15. PMID: 35158420; PMCID: PMC8901942.
- Norelli F, Schiappoli M, Senna G, Pinter P, Olivieri B, Ottaviano G, et al. Adherence to Intranasal Steroids in Chronic Rhinosinusitis with Nasal Polyposis Prior to and during Biologic Therapy: A Neglected Matter. J Clin Med. 2024 Feb 13;13(4):1066. doi: 10.3390/jcm13041066. PMID: 38398379; PMCID: PMC10889709.
- Liao Z, Xue Z, Huang J, Mao L, Lin C, Lin E. Combined corticosteroid therapy enhances outcomes of endoscopic sinus surgery in chronic rhinosinusitis with nasal polyps: a prospective cohort study. Am J Transl Res. 2025 Jul 15;17(7):5173–5185. doi: 10.62347/XYEC4626. PMID: 40821092; PMCID: PMC12351598.
- Almosnino G, Little RE. Surgical management of rhinosinusitis for the allergist-immunologist. Ann Allergy Asthma Immunol. 2023 Sep;131(3):311–316. doi: 10.1016/j.anai.2023.05.015. Epub 2023 May 21. PMID: 37220810.
Language: English
Page range: 83 - 103
Submitted on: Apr 24, 2026
Accepted on: May 11, 2026
Published on: Jun 28, 2026
Published by: The Medical Library named after S. Konopka in Warsaw
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 Radosław Jan Walkowski, Aleksandra Suchołbiak, Oskar Mikołajczyk, published by The Medical Library named after S. Konopka in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.